Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Aug;2(2):153-60.
doi: 10.1016/j.molonc.2008.05.003. Epub 2008 May 28.

Innovations, challenges and future prospects of oncoproteomics

Affiliations
Review

Innovations, challenges and future prospects of oncoproteomics

Kewal K Jain. Mol Oncol. 2008 Aug.

Abstract

Oncoproteomics is playing an increasingly important role in the diagnosis and management of cancer as well as in the development of personalized treatment of cancer. Innovative proteomic technologies relevant to cancer are described briefly, which are helping in the understanding of mechanism of drug resistance in cancer and will provide some leads to improve the management. Most important of these are nanoproteomics, i.e. application of nanobiotechnology to proteomics is playing an important role in nanooncology. Examples of some cancers will be given to point out the challenges and future prospects of oncoproteomics including those involving translation of technologies from the bench to the bedside.

PubMed Disclaimer

Figures

Figure 1
Figure 1
This figure shows the interrelationships of oncoproteomics with other technologies used. Oncogenomics plays an important role by diagnostics as well as drug discovery, as both are components of personalized medicine. Technologies such as nanobiotechnology can also enhance both diagnostics and drug development for cancer.

Similar articles

Cited by

References

    1. Carney, W.P. , Leitzel, K. , Ali, S. , Neumann, R. , Lipton, A. , 2007. HER-2/neu diagnostics in breast cancer. Breast Cancer Res. 9, 207 - PMC - PubMed
    1. Cho, W.C. , Cheng, C.H. , 2007. Oncoproteomics: current trends and future perspectives. Expert Rev. Proteomics 4, 401–410. - PubMed
    1. Conrad, D.H. , Goyette, J. , Thomas, P.S. , 2008. Proteomics as a method for early detection of cancer: a review of proteomics, exhaled breath condensate, and lung cancer screening. J. Gen. Intern. Med. 23, (Suppl. 1) 78–84. - PMC - PubMed
    1. D'Amico, T.A. , 2008. Molecular biologic staging of lung cancer. Ann. Thorac. Surg. 85, S737–S742. - PubMed
    1. Drev, P. , Grazio, S.F. , Bracko, M. , 2008. Tissue microarrays for routine diagnostic assessment of HER2 status in breast carcinoma. Appl. Immunohistochem. Mol. Morphol. 16, 179–184. - PubMed